These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3133121)

  • 21. Transdermal therapeutic systems--actual state and future developments.
    Asmussen B
    Methods Find Exp Clin Pharmacol; 1991 Jun; 13(5):343-51. PubMed ID: 1921571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal delivery and the premature neonate.
    Barrett DA; Rutter N
    Crit Rev Ther Drug Carrier Syst; 1994; 11(1):1-30. PubMed ID: 7704917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vivo penetration of isosorbide dinitrate from a transdermal therapeutic system in rat skin].
    Janicki S; Gabiga H; Szczepańska M
    Pharmazie; 1993 Nov; 48(11):865. PubMed ID: 8295920
    [No Abstract]   [Full Text] [Related]  

  • 25. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L
    Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The promise of transdermal drug delivery.
    Nimmo WS
    Br J Anaesth; 1990 Jan; 64(1):7-10. PubMed ID: 2105738
    [No Abstract]   [Full Text] [Related]  

  • 33. [The in vitro release rate of isosorbide dinitrate in a transdermal therapeutic membrane system].
    Janicki S; Gabiga H
    Pharmazie; 1989 Jan; 44(1):68-9. PubMed ID: 2727039
    [No Abstract]   [Full Text] [Related]  

  • 34. [Management of transdermal therapeutics in perioperative care].
    Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse dermatologic reactions to transdermal drug delivery systems.
    Hogan DJ; Maibach HI
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.
    Zhan X; Chen S; Tang G; Mao Z
    Eur J Pharm Biopharm; 2007 Jun; 66(3):429-34. PubMed ID: 17196806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.
    Mayes S; Ferrone M
    Ann Pharmacother; 2006 Dec; 40(12):2178-86. PubMed ID: 17164395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro/in vivo functionality of Catapres-TTS.
    Enscore DJ; Osborne JL; Shaw JE
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.